Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:36 AM ET

Sponsor Check › Management entity

Stuart Hendon

Management entity named on Form D filings · AL · Dec 20, 2017 → Dec 20, 2017

1deal (issuers)

$11.5Mreported sold

23investors

1Form D filing

2017year on file

Follow this entity Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:15 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Stuart Hendon is a management entity listed as a director on 1 SEC Form D filing by 1 issuer in Dec 2017: Vitruvias Therapeutics, Inc. (Auburn, AL — pharmaceuticals — 2017; $11.5M reported sold to 23 investors).

What this means One deal on file with the SEC, filed Dec 2017. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Bryce M Harvey (1 shared filing), Carl Leo Whatley, Jr. (1 shared filing), Charles T. Smith (1 shared filing), Roger D Graben (1 shared filing) and Thomas A Main (1 shared filing).

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stuart. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 1 public filing for Stuart Hendon and found 2 differences, 1 worth asking the sponsor about: Stuart Hendon is no longer listed on the Jan 5, 2018 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Stuart Hendon has not run yet — it is joining a line of 19,130 names; searches run around the clock at the hosts' allowed rate. Searched so far: 31 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:15 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Stuart Hendon..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:15 AM ET.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

2 differences found between the filings for Stuart Hendon — 1 worth asking about (compared 1 filing on Oct 24, 2026)

Worth asking · Dec 20, 2017 – Jan 5, 2018

Stuart Hendon is no longer listed on the Jan 5, 2018 amendment — Vitruvias Therapeutics, Inc.

Stuart Hendon appears on the Dec 20, 2017 Form D (director) but not on the Jan 5, 2018 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Dec 20, 2017 ↗Form D/A · Jan 5, 2018 ↗Stuart Hendon — PartnerFacts page ↗Vitruvias Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Dec 20, 2017 ↗ (Dec 20, 2017)
Form D/A · Jan 5, 2018 ↗ (Jan 5, 2018)
Stuart Hendon — PartnerFacts page ↗
Vitruvias Therapeutics, Inc. — PartnerFacts page ↗ (Jan 5, 2018)

Note · Dec 20, 2017 – Jan 5, 2018

Address moved from Auburn, AL to New York, NY — Vitruvias Therapeutics, Inc.

The people listed on the Dec 20, 2017 filing give Auburn, AL; on the Jan 5, 2018 filing they give New York, NY.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Dec 20, 2017 ↗Form D/A · Jan 5, 2018 ↗Vitruvias Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Dec 20, 2017 ↗ (Dec 20, 2017)
Form D/A · Jan 5, 2018 ↗ (Jan 5, 2018)
Vitruvias Therapeutics, Inc. — PartnerFacts page ↗ (Jan 5, 2018)

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 1 offering report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,510,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Dec 20, 2017 D Vitruvias Therapeutics, Inc. File 021-301275	$0	$0	$1,510,000 (est.) Bryce Harvey owns the majority of interests in H2-Pharma,LLC, which loaned money to the issuer. $1,500,000 will be used to pay down principal of that loan. About $10,000 will be used to pay officers & directors interest on short term loans they made.	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this entity is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Stuart Hendon on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pharmaceuticals

Vitruvias Therapeutics, Inc.

Auburn, AL · Dec 20, 2017

Dec 20, 2017 · D · $0 sold of $11,500,000 · 0 investors · min. $25,000 · role: Director EDGAR ↗

Raised $11.5M from 23 investors (100% of the $11.5M target) as of the latest filing. Stuart is listed as director.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Stuart 5

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

No photo found yet (own website and image search run after this page is viewed)

Person